Literature DB >> 25403610

Reinnervation of renal afferent and efferent nerves at 5.5 and 11 months after catheter-based radiofrequency renal denervation in sheep.

Lindsea C Booth1, Erika E Nishi2, Song T Yao2, Rohit Ramchandra2, Gavin W Lambert2, Markus P Schlaich2, Clive N May2.   

Abstract

Previous studies indicate that catheter-based renal denervation reduces blood pressure and renal norepinephrine spillover in human resistant hypertension. The effects of this procedure on afferent sensory and efferent sympathetic renal nerves, and the subsequent degree of reinnervation, have not been investigated. We therefore examined the level of functional and anatomic reinnervation at 5.5 and 11 months after renal denervation using the Symplicity Flex catheter. In normotensive anesthetized sheep (n=6), electric stimulation of intact renal nerves increased arterial pressure from 99±3 to 107±3 mm Hg (afferent response) and reduced renal blood flow from 198±16 to 85±20 mL/min (efferent response). In a further group (n=6), immediately after denervation, renal sympathetic nerve activity was absent and the responses to electric stimulation were abolished. At 11 months after denervation (n=5), renal sympathetic nerve activity and the responses to electric stimulation were at normal levels. Immunohistochemical staining for renal efferent (tyrosine hydroxylase) and renal afferent nerves (calcitonin gene-related peptide), as well as renal norepinephrine levels, was normal 11 months after denervation. Findings at 5.5 months after denervation were similar (n=5). In summary, catheter-based renal denervation effectively ablated the renal afferent and efferent nerves in normotensive sheep. By 11 months after denervation the functional afferent and efferent responses to electric stimulation were normal. Reinnervation at 11 months after denervation was supported by normal anatomic distribution of afferent and efferent renal nerves. In view of this evidence, the mechanisms underlying the prolonged hypotensive effect of catheter-based renal denervation in human resistant hypertension need to be reassessed.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  cardiovascular diseases; catheter ablation; electric stimulation

Mesh:

Substances:

Year:  2014        PMID: 25403610     DOI: 10.1161/HYPERTENSIONAHA.114.04176

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  47 in total

Review 1.  Resistant Hypertension: An Update of Experimental and Clinical Findings.

Authors:  Anping Cai; David A Calhoun
Journal:  Hypertension       Date:  2017-05-15       Impact factor: 10.190

Review 2.  Device-Based Therapy for Drug-Resistant Hypertension: An Update.

Authors:  Ping Li; Mark Nader; Kousalya Arunagiri; Vasilios Papademetriou
Journal:  Curr Hypertens Rep       Date:  2016-08       Impact factor: 5.369

Review 3.  Device-Based Approaches for the Treatment of Arterial Hypertension.

Authors:  Jens Jordan
Journal:  Curr Hypertens Rep       Date:  2017-07       Impact factor: 5.369

4.  Bipolar radiofrequency renal denervation with the Vessix catheter in patients with resistant hypertension: 2-year results from the REDUCE-HTN trial.

Authors:  H Sievert; J Schofer; J Ormiston; U C Hoppe; I T Meredith; D L Walters; M Azizi; J Diaz-Cartelle
Journal:  J Hum Hypertens       Date:  2017-01-12       Impact factor: 3.012

Review 5.  Catheter-Based Renal Nerve Ablation as a Novel Hypertension Therapy: Lost, and Then Found, in Translation.

Authors:  John W Osborn; Christopher T Banek
Journal:  Hypertension       Date:  2018-01-02       Impact factor: 10.190

Review 6.  Device-based therapies for arterial hypertension.

Authors:  Lucas Lauder; Michel Azizi; Ajay J Kirtane; Michael Böhm; Felix Mahfoud
Journal:  Nat Rev Cardiol       Date:  2020-04-14       Impact factor: 32.419

Review 7.  Renal sympathetic denervation in therapy resistant hypertension - pathophysiological aspects and predictors for treatment success.

Authors:  Karl Fengler; Karl Philipp Rommel; Thomas Okon; Gerhard Schuler; Philipp Lurz
Journal:  World J Cardiol       Date:  2016-08-26

Review 8.  Renal Nerve Stimulation as Procedural End Point for Renal Sympathetic Denervation.

Authors:  Annemiek F Hoogerwaard; Mark R de Jong; Arif Elvan
Journal:  Curr Hypertens Rep       Date:  2018-03-19       Impact factor: 5.369

9.  Spike rate of multi-unit muscle sympathetic nerve fibers after catheter-based renal nerve ablation.

Authors:  Jens Tank; Karsten Heusser; Julia Brinkmann; Bernhard M Schmidt; Jan Menne; Johann Bauersachs; Hermann Haller; André Diedrich; Jens Jordan
Journal:  J Am Soc Hypertens       Date:  2015-07-31

Review 10.  Renal Denervation for Treatment of Hypertension: a Second Start and New Challenges.

Authors:  Alexandre Persu; Sverre Kjeldsen; Jan A Staessen; Michel Azizi
Journal:  Curr Hypertens Rep       Date:  2016-01       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.